AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (October 10, 2008). doi:10.1152/ajplung.90207.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/L1007    most recent
90207.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Saux, O.
Right arrow Articles by Jourdan-Le Saux, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Saux, O.
Right arrow Articles by Jourdan-Le Saux, C.
Submitted on February 22, 2008
Revised on September 19, 2008
Accepted on October 4, 2008

The role of caveolin-1 in pulmonary matrix remodeling and mechanical properties

Olivier Le Saux1, Kelsa Teteers1, Shelley Kay Miyasato1, Ji Won Choi2, Garrett Nakamatsu1, James A. Richardson3, Barry Starcher4, Elaine C. Davis2, Elizabeth K. Tam1, and Claude Jourdan-Le Saux1*

1 John A. Burns School of Medicine
2 McGill University
3 University of Texas Southwestern Medical Center
4 University of Texas Health Science Center at Tyler

* To whom correspondence should be addressed. E-mail: Claude{at}hawaii.edu.

Caveolin-1 (cav1) is a 22kDa membrane protein essential to the formation of small invaginations in the plasma membrane, called caveolae. The cav1 gene is expressed primarily in adherent cells such as endothelial and smooth muscle cells and fibroblasts. Caveolae contain a variety of signaling receptors and cav1 notably down-regulates transforming growth factor (TGF)-{beta} signal transduction. In pulmonary pathologies such as interstitial fibrosis or emphysema, altered mechanical properties of the lungs are often associated with abnormal extracellular matrix (ECM) deposition. In this study, we examined the physiological functions and the deposition of ECM in cav1-/- mice at various ages (1 to 12 months). Cav1-/- mice lack caveolae and by 3 months of age have significantly reduced lung compliance and increased elastance and airway resistance. Pulmonary extravasation of fluid, as part of the cav1-/- mouse phenotype, probably contributed to the alteration of compliance, which was compounded by a progressive increase in deposition of collagen fibrils in airways and parenchyma. We also found that the increased elastance was caused by abundant elastic fiber deposition primarily around airways in cav1-/- mice at least 3 months old. These observed changes in the ECM composition probably also contributes to the increased airway resistance. The higher deposition of collagen and elastic fibers was associated with increased tropoelastin and col1{alpha}2 and col3{alpha}1 gene expression in lung tissues, which correlated tightly with increased TGF-{beta}/Smad signal transduction. Our study illustrates that perturbation of cav1 function may contribute to several pulmonary pathologies as the result of the important role played by cav1, as part of the TGF-{beta} signaling pathway, in the regulation of the pulmonary ECM.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.